Pediatric Crohn's Disease

被引:13
|
作者
von Allmen, Daniel [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Surg, 3333 Burnet Ave,ML 2023, Cincinnati, OH 45229 USA
关键词
pediatric; Crohn's disease; nutritional therapy; surgery; INFLAMMATORY-BOWEL-DISEASE; TO-END ANASTOMOSIS; HAND-SEWN ANASTOMOSES; LAPAROSCOPIC ILEOCECAL RESECTION; SIDE STAPLED ANASTOMOSIS; OPEN ILEOCOLIC RESECTION; QUALITY-OF-LIFE; POSTOPERATIVE RECURRENCE; SURGICAL-TREATMENT; INTESTINAL RESECTION;
D O I
10.1055/s-0037-1609022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The incidence of Crohn's disease in the pediatric population is increasing. While pediatric patients with Crohn's disease exhibit many of the characteristics of older patients, there are important differences in the clinical presentation and course of disease that can impact the clinical decisions made during treatment. The majority of children are diagnosed in the early teen years, but subgroups of very early onset and infantile Crohn's present much earlier and have a unique clinical course. Treatment paradigms follow the traditional laddered approach, but growth and development represent special considerations that must be given to pediatric-specific complications of the treatment and disease. Surgical intervention is an important component of Crohn's management and is often employed to allow improved nutritional intake or decrease reliance on medical treatments that compromise growth.
引用
收藏
页码:80 / 88
页数:9
相关论文
共 50 条
  • [1] USTEKINUMAB IN PEDIATRIC CROHN'S DISEASE
    Dilillo, A.
    Civitelli, F.
    Oliva, S.
    Votto, M.
    Aloi, M.
    Isoldi, S.
    Mallardo, S.
    Rossi, P.
    Viola, F.
    Cucchiara, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 : E262 - E263
  • [2] INFLIXIMAB FOR PEDIATRIC CROHN'S DISEASE
    Hoffman, I.
    Vermeire, S.
    Van Assche, G.
    Rutgeerts, P.
    [J]. DRUGS OF TODAY, 2008, 44 (08) : 615 - 628
  • [3] Pediatric Crohn's disease patients
    Pittschieler, K.
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2006, 154 (11) : 1124 - 1124
  • [4] Pediatric Management of Crohn?s Disease
    Mitchel, Elana B.
    Rosh, Joel R.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (02) : 401 - 424
  • [5] Adalimumab in pediatric Crohn's disease
    Patel, Ashish S.
    Suarez, Lisbet D.
    Rosh, Joel R.
    [J]. IMMUNOTHERAPY, 2016, 8 (02) : 127 - 133
  • [6] The pharmacotherapeutic management of pediatric Crohn?s disease
    Zimmerman, Lori
    Bousvaros, Athos
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (17) : 2161 - 2168
  • [7] The use of infliximab in pediatric Crohn's Disease
    Khan, S
    Henderson, WA
    Kocoshis, SA
    Goyal, A
    Di Lorenzo, C
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A210 - A210
  • [8] Infliximab therapy for pediatric Crohn's disease
    Veres, Gabor
    Baldassano, Robert N.
    Mamula, Petar
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (12) : 1869 - 1880
  • [9] Infliximab therapy for pediatric Crohn's disease
    Oliva-Hemker, M
    Roper, S
    Cuffari, C
    Lake, A
    Wilson, L
    Leibowitz, I
    Duffy, L
    Tuchman, D
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A612 - A613
  • [10] SLEEP PATTERNS IN PEDIATRIC CROHN'S DISEASE
    Winberry, Gabriel B.
    Razafindrarivo, Faniry
    Douglas, Leslie
    Sidamo, Amanuel
    Slaughter, James C.
    Malow, Beth
    Buchowski, Maciej
    Acra, Sari
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S432 - S433